SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,330.80 -180.24
(-0.36%)

Dow Jones

7,129.46 -29.44
(-0.41%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,468.22 -8.24
(-0.08%)

Forex

USD-INR

93.75 0.31
(0.34%)

EUR-INR

109.98 0.10
(0.09%)

GBP-INR

126.66 0.42
(0.33%)

JPY-INR

0.59 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Shukra Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524632

INE551C01044

1.5028279

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

47.4

1390.71

EPS(TTM)

Face Value()

Div & Yield %

0.67

0.03

Back

prismx global ventures ltd

UltraTech Cement consolidated net profit rises 26.92% in the December 2025 quarter

Jan 24,2026

Net profit of UltraTech Cement rose 26.92% to Rs 1725.40 crore in the quarter ended December 2025 as against Rs 1359.43 crore during the previous quarter ended December 2024. Sales rose 22.78% to Rs 21829.68 crore in the quarter ended December 2025 as against Rs 17778.83 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	21829.68	17778.83	23
OPM %	17.91	16.27	-
PBDT	3554.15	2684.05	32
PBT	2372.25	1691.27	40
NP	1725.40	1359.43	27

76,664.21 -999.79 ( -1.29%)

49,330.80 -180.24 (-0.36%)

7,129.46 -29.44 (-0.41%)

59,744.07 603.84 (1.02%)

10,468.22 -8.24 (-0.08%)

93.75 0.31 (0.34%)

109.98 0.10 (0.09%)

126.66 0.42 (0.33%)

0.59 0.00 (0.23%)